Astherna stands as a cutting-edge RNA therapy company, with a devoted team of specialists focused on treating retinal disorders through antisense oligonucleotides. We target previously untreated conditions, such as Stargardt disease and USH2A-associated retinal disease, with the aim to meet the urgent needs of a global community with hundreds of thousands of affected individuals.
At Astherna, our mission is clear: prevent blindness and offer effective therapeutic innovations for these challenging disorders. We are committed to accelerating the journey from bench to clinical application, all while ensuring our pipeline prioritizes both efficacy and safety to maximize positive impacts on patients’ lives.
Company Details
- Employees
- 6
- Founded
- 2021
- Address
- Reinier Postlaan, Nijmegen,gelderland,netherlands
- Industry
- Pharmaceutical Manufacturing
- NAICS
-
Pharmaceutical and Medicine ManufacturingMedicinal and Botanical ManufacturingPharmaceutical Preparation ManufacturingIn-Vitro Diagnostic Substance ManufacturingBiological Product (except Diagnostic) Manufacturing
- Website
- https://astherna.com/
- Keywords
- Eindhoven.
- HQ
- Nijmegen, Gelderland
Astherna Questions
Astherna's website is https://astherna.com/
Astherna's LinkedIn profile is https://nl.linkedin.com/company/astherna
Astherna has
6 employees.
View email and phone details for 6
employees at Astherna.
Astherna's industry is
Pharmaceutical Manufacturing
Astherna's top competitors are
Avigi Therapeutics,
Glycostem Therapeutics,
Allergios,
Suprapolix Bv,
Laigo Bio,
Divvly,
Secuped,
Sencilia,
Phlox Therapeutics,
Cordys Analytics.
Astherna's categories are Pharmaceutical Manufacturing
Astherna's founding year is 2021
